Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report

Tadafumi Asaoka; Shigeru Marubashi; Keizo Dono; Naoki Hama; Chiwan Kim; Shogo Kobayashi; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Morito Monden; Yuichiro Doki; Masaki Mori

Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report

Tadafumi Asaoka, Shigeru Marubashi, Keizo Dono, Naoki Hama, Chiwan Kim, Shogo Kobayashi, Yutaka Takeda, Hiroaki Nagano, Koji Umeshita, Morito Monden, Yuichiro Doki, Masaki Mori

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.

Original language	English
Pages (from-to)	2086-2087
Number of pages	2
Journal	Gan to kagaku ryoho. Cancer & chemotherapy
Volume	35
Issue number	12
Publication status	Published - Nov 2008
Externally published	Yes

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{4a9ce76f49df42eab749381d2ccb82e6,

title = "Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report",

abstract = "We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.",

author = "Tadafumi Asaoka and Shigeru Marubashi and Keizo Dono and Naoki Hama and Chiwan Kim and Shogo Kobayashi and Yutaka Takeda and Hiroaki Nagano and Koji Umeshita and Morito Monden and Yuichiro Doki and Masaki Mori",

year = "2008",

month = nov,

language = "English",

volume = "35",

pages = "2086--2087",

journal = "Gan to kagaku ryoho. Cancer & chemotherapy",

issn = "0385-0684",

publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",

number = "12",

}

TY - JOUR

T1 - Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report

AU - Asaoka, Tadafumi

AU - Marubashi, Shigeru

AU - Dono, Keizo

AU - Hama, Naoki

AU - Kim, Chiwan

AU - Kobayashi, Shogo

AU - Takeda, Yutaka

AU - Nagano, Hiroaki

AU - Umeshita, Koji

AU - Monden, Morito

AU - Doki, Yuichiro

AU - Mori, Masaki

PY - 2008/11

Y1 - 2008/11

N2 - We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.

AB - We report on the treatment experience of five living-donor liver transplantation (LDLT) recipients for hepatocellular carcinoma (HCC) with pulmonary metastases. Between March 1998 and December 2007, five patients who underwent LDLT for HCC were identified with a routine follow-up of pulmonary metastases: Two patients underwent a radical resection for pulmonary recurrence of HCC, Two patients were only observed by palliative treatment, and one patient had chemotherapy using S-1/IFN. The survival range from pulmonary recurrence of HCC was 7.5 to 43.0 months and the median survival time was 18.9 months. Only one of the 5 patients who underwent a surgical resection of pulmonary recurrence is still alive without a new recurrence for a long period of time.

UR - http://www.scopus.com/inward/record.url?scp=58749113473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58749113473&partnerID=8YFLogxK

M3 - Article

C2 - 19106532

AN - SCOPUS:58749113473

SN - 0385-0684

VL - 35

SP - 2086

EP - 2087

JO - Gan to kagaku ryoho. Cancer & chemotherapy

JF - Gan to kagaku ryoho. Cancer & chemotherapy

IS - 12

ER -

Management of pulmonary recurrence of hepatocellular carcinoma after receiving a living-donor liver transplantation--a case report

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Other files and links

Fingerprint

Cite this